Amlodipine
Showing 1 - 25 of 721
Hypertension, Coronary Artery Disease Trial in Vadodara (Amlodipine Freeze-Dried Powder for Oral Solution 5 mg, Norvasc 5 mg
Active, not recruiting
- Hypertension
- Coronary Artery Disease
- Amlodipine Freeze-Dried Powder for Oral Solution 5 mg
- Norvasc 5 mg tablets of Pfizer Labs
-
Vadodara, Gujarat, IndiaAccutest Research Laboratories (I) Pvt. Ltd.
Apr 10, 2023
Primary Hypertension Trial (Amlodipine, Olmesartan, Hydrochlorothiazide)
Not yet recruiting
- Primary Hypertension
- Amlodipine
- +3 more
- (no location specified)
Jun 15, 2023
Healthy Volunteers Trial in Seoul (Irbesartan High/Amlodipine FDC, Irbesartan High, Amlodipine)
Active, not recruiting
- Healthy Volunteers
- Irbesartan High/Amlodipine FDC
- +2 more
-
Seoul, Korea, Republic ofH Plus Yangji Hospital
Jan 26, 2023
Healthy Volunteers Trial in Seoul (Irbesartan/Amlodipine FDC, Irbesartan, Amlodipine)
Active, not recruiting
- Healthy Volunteers
- Irbesartan/Amlodipine FDC
- +2 more
-
Seoul, Korea, Republic ofH Plus Yangji Hospital
Jan 8, 2023
Healthy Volunteers Trial in Seoul (Irbesartan/Amlodipine High FDC, Irbesartan, Amlodipine High)
Active, not recruiting
- Healthy Volunteers
- Irbesartan/Amlodipine High FDC
- +2 more
-
Seoul, Korea, Republic ofH Plus Yangji Hospital
Jan 8, 2023
Amlodipine/Atorvastatin/Perindopril Single Pill Combination
Not yet recruiting
- Arterial Hypertension
- HTN
- Amlodipine 5 mg + atorvastatin 10 mg + perindopril arginine 5 mg
- +2 more
- (no location specified)
Mar 1, 2023
Dyslipidemias, Hypertension Trial in Daegu (Rosuampin 10/5mg, Rosuampin 20/5mg, Amlodipine/Atorvastatin 5/20mg)
Completed
- Dyslipidemias
- Hypertension
- Rosuampin 10/5mg
- +2 more
-
Daegu, Korea, Republic ofDaegu Catholic Univ. Medical Center
Oct 10, 2022
Hypertension Trial in Guangdong (Amlodipine besylate tablets (trade name: Norfloxacin ®), Amlodipine besylate controlled-release
Not yet recruiting
- Hypertension
- Amlodipine besylate tablets (trade name: Norfloxacin ®)
- Amlodipine besylate controlled-release tablets
-
Guangdong, Guangzhou, ChinaZhujiang Hospital of Southern Medical University
Jan 3, 2023
Essential Hypertension Trial in Korea, Republic of (Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg,
Not yet recruiting
- Essential Hypertension
- Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg
- Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mg
-
Seoul, Gyeonggi-do, Korea, Republic of
- +11 more
Sep 11, 2023
S-amlodipine in Essential HypertensIon and Assessment of Blood
Recruiting
- Essential Hypertension
-
Seongnam-si, Gyeonggi-do, Korea, Republic ofBundang Seoul University Hospital
Nov 8, 2023
Essential Hypertension Trial in Seoul (Irbesartan/Amlodipine low, Irbesartan/Amlodipine high, Irbesartan)
Recruiting
- Essential Hypertension
- Irbesartan/Amlodipine low
- +2 more
-
Seoul, Korea, Republic ofSeverance Hospital
Jul 24, 2022
Atorvastatin Antihypertensive Effect Trial in Shaqra (Amlodipine 5 MG Oral Tablet, Amlodipine 5 MG / Atorvastatin 10 MG Oral
Completed
- Atorvastatin Antihypertensive Effect
- Amlodipine 5 MG Oral Tablet
- Amlodipine 5 MG / Atorvastatin 10 MG Oral Tablet
-
Shaqra, Riyadh, Saudi ArabiaShaqra University
Jan 9, 2023
Hypercholesterolemia, Hypertension, Cholesterol Deposition Trial (Amlodipine)
Completed
- Hypercholesterolemia
- +2 more
- Amlodipine
- (no location specified)
Jul 18, 2022
Bioequivalence Trial in Moscow (Perindopril/Indapamide/Amlodipine 8 mg/2.5 mg/10 mg tablet / Triplixam® 10 mg/2.5 mg/10 mg
Recruiting
- Bioequivalence
- Perindopril/Indapamide/Amlodipine 8 mg/2.5 mg/10 mg tablet / Triplixam® 10 mg/2.5 mg/10 mg tablet
-
Moscow, Russian FederationLigand Research LLC
Jul 7, 2023
Hypertension Trial (Losartan (+) amlodipine, Placebo to match losartan/amlodipine tablets, Amlodipine camsylate)
Completed
- Hypertension
- Losartan (+) amlodipine
- +3 more
- (no location specified)
Feb 7, 2022
Frozen Embryo Transfer Trial in Montpellier, Nîmes (Amlodipine 5mg, Placebo)
Recruiting
- Frozen Embryo Transfer
- Amlodipine 5mg
- Placebo
-
Montpellier, France
- +1 more
Jul 28, 2022
Bioequivalence, Healthy Subjects Trial in Amman (PERINDOPRES® TRIO, 8 mg perindopril tert-butylamine / 2.5 mg indapamide / 10 mg
Completed
- Bioequivalence
- Healthy Subjects
- PERINDOPRES® TRIO, 8 mg perindopril tert-butylamine / 2.5 mg indapamide / 10 mg amlodipine tablets
- TRIPLIXAM® 10 mg /2.5 mg/10 mg, 10 mg perindopril arginine / 2.5 mg indapamide / 10 mg amlodipine film-coated tablets
-
Amman, JordanInternational Pharmaceutical Research Center
Jul 20, 2022
Essential Hypertension Trial in Seoul (Irbesartan/Amlodipine, Irbesartan)
Recruiting
- Essential Hypertension
-
Seoul, Korea, Republic ofHanyang University Seoul Hospital
Jul 24, 2022
Hypertension Trial in Brazil (candesartan cilexetil + chlorthalidone + amlodipine, Exforge HCT® (valsartan 160mg +
Not yet recruiting
- Hypertension
- candesartan cilexetil + chlorthalidone + amlodipine
- Exforge HCT® (valsartan 160mg + hydrochlorothiazide 12.5mg + amlodipine 5mg)
-
Rio Branco, AC, Brazil
- +21 more
Jun 26, 2023
Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ
Recruiting
- Hypertension,Essential
-
Seoul, Korea, Republic ofSeoul National University Bundang Hospital
Jul 7, 2022
Patients Treated With Telmisartan/Hydrochlorothiazide or
Withdrawn
- Hypertension
- subjects treated with telmisartan/hydrochlorothiazide
- +3 more
-
Tokyo, JapanNippon Boehringer Ingelheim Co., Ltd.
Jun 23, 2022
Hypertension Trial in China (Amlodipine besylate tablets, Amlodipine besylate And Folic Acid Tablets, 5-methyltetrahydrofolate
Not yet recruiting
- Hypertension
- Amlodipine besylate tablets
- +2 more
-
Beijing, China
- +4 more
Mar 30, 2022
Hypertension, Hyperlipidemias Trial in Seoul (Amlodipine/Olmesartan 10/40mg (Combination drug), Rosuvastatin 20mg, Olmesartan 40
Completed
- Hypertension
- Hyperlipidemias
- Amlodipine/Olmesartan 10/40mg (Combination drug), Rosuvastatin 20mg
- +2 more
-
Seoul, Korea, Republic ofSeoul national university bundang hospital
Dec 20, 2021